Stem Cell Therapeutics Corp., of Calgary, Alberta, received U.S. Patent No...The company also received U.S. Patent No...SuperGen Inc., of Dublin, Calif., received U.S. Patent No

Neuren Pharmaceuticals Ltd., of Sydney, Australia, was granted U.S. Patent No...OxiGene Inc., of Waltham, Mass., was issued U.S. Patent No...Phylonix Pharmaceuticals Inc., of Cambridge, Mass., received U.S. Patent No

Alnylam Pharmaceuticals Inc., of Cambridge, Mass., received U.S. Patent No...Ambrilia Biopharma Inc., of Montreal, received U.S. Patent No...Curis Inc., of Cambridge, Mass., received U.S. Patent No

EntreMed Inc., of Rockville, Md., was issued U.S. Patent No...GenoMed Inc., of St. Louis, received U.S. Patent No...Introgen Therapeutics Inc., of Austin, Texas, received U.S. Patent No

DiagnoCure Inc., of Quebec City, was granted U.S. Patent No

Morphotek Inc., of Exton, Pa., was issued U.S. Patent No...Provectus Pharmaceuticals Inc., of Knoxville, Tenn., received U.S. Patent No...Sirna Therapeutics Inc., of San Francisco, received U.S. Patent No

Androclus Therapeutics Inc., of San Diego, received U.S. Patent No...Cel-Sci Corp., of Vienna, Va., received U.S. Patent No...MannKind Corp., of Valencia, Calif., received U.S. Patent No

The patent would cover immunotherapy approaches directed against the 5T4 tumor antigen...Source MDx, of Boulder, Colo., was issued U.S. Patent No

Nanosphere Inc., of Northbrook, Ill., received U.S. Patent No...NovaDel Pharma Inc., of Flemington, N.J., received U.S. Patent Nos...OncoMed Pharmaceuticals Inc., of Mountain View, Calif., was granted U.S. Patent No

MediQuest Therapeutics Inc., of Bothell, Wash., was issued U.S. Patent No...Nanogen Inc., of San Diego, received U.S. Patent No...Nanogen's subsidiary, Epoch Biosciences Inc., of Bothell, Wash., recently received U.S. Patent No

Nanogen Inc., of San Diego, received U.S. Patent No...Senomyx Inc., of La Jolla, Calif., received U.S. Patent No

EntreMed Inc., of Rockville, Md., was issued U.S. Patent No...Genmab A/S, of Copenhagen, Denmark, received a patent for HuMax-HepC, a fully human antibody in preclinical development to prevent re-infection with the hepatitis C virus after liver transplantation...Mobious Genomics Ltd., of Exeter, UK, received a notice of allowance for U.S. Patent No

Stressgen Biotechnologies Corp., of San Diego, received U.S. Patent No...Targeted Genetics Corp., of Seattle, was issued U.S. Patent No...The company also was granted U.S. Patent No

Pro-Pharmaceuticals Inc., of Newton, Mass., received U.S. Patent No...PSivida Ltd., of Perth, Australia, received U.S. Patent No...Semafore Pharmaceuticals Inc., of Indianapolis, received U.S. Patent No

Arena Pharmaceuticals Inc., of San Diego, received U.S. Patent No...Biosensors International Group Ltd., of Singapore, received U.S. Patent No...Genaera Corp., of Plymouth Meeting, Pa., received U.S. Patent No

Bavarian Nordic A/S, of Copenhagen, Denmark, received U.S. Patent No...eGene Inc., of Irvine, Calif., received U.S. Patent No...Morphotek Inc., of Exton, Pa., received U.S. Patent No

Targepeutics Inc., of Hershey, Pa., received U.S. Patent No...Targeted Genetics Corp., of Seattle, said U.S. Patent No

Nanogen Inc., of San Diego, was granted U.S. Patent No...Neurocrine Biosciences Inc. , of San Diego, received U.S. Patent No...Odyssey Thera Inc., of San Ramon, Calif., received U.S. Patent Nos

Borean Pharma A/S, of Aarhus, Denmark, received U.S. Patent No...Cholestech Corp., of Hayward, Calif., received U.S. Patent No...Inc. , of Bothell, Wash., received U.S. Patent No